CGEn is excited to announce the addition of new members to our Board of Directors and Scientific Advisory Board (SAB), […]

Meredith McLaren named CEO of CGEn The Board of Directors and Executive Committee of CGEn, Canada’s national platform for genome […]

As the world grappled with the complexities of the COVID-19 pandemic, scientists raced to comprehend the factors influencing the severity […]

Unleashing the Potential: The Transformative Role of Artificial Intelligence in Precision Medicine By: Shantala Hari Dass From left to right: […]

Chair of CGEn’s Scientific Advisory Board, Dr. Edward M. Rubin has been named a Fellow of the prestigious Royal Society of Canada (RSC) in recognition of his long-term contributions to advancing genomics internationally.

With this renewed support from the Government of Canada through the CFI, CGEn is poised to embark upon the next stage of its strategic vision, continuing to provide the leading genomic infrastructure for Canada’s research and innovation community.

Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.

Diverse, large-scale health genomic resources are key to realizing the true potential of research, and to fully exploit the power of new health technologies based on artificial intelligence (AI), to improve health for all.